Olowofela Abimbola O, Isah Ambrose O
Department of Medicine, Clinical Pharmacology and Therapeutics Unit, University of Benin, University of Benin Teaching Hospital, Benin City, Edo State, Nigeria.
Ann Afr Med. 2017 Jul-Sep;16(3):114-119. doi: 10.4103/aam.aam_6_17.
There has been a dearth of comprehensive data on the profile of adverse reactions to antihypertensive medicines in the Nigerian setting despite increased use.
This study was aimed to characterize the adverse reactions experienced in the homogenously black African population.
The study was carried out at the University of Benin Teaching Hospital, Benin City, Nigeria, in consenting eligible hypertensive patients ≥18 years. Adverse reactions were sought using patient's self-report and a medicine-induced symptom checklist.
A total of 514 patients (340 females) aged 22-97 years were studied. Thirteen percent, 27.6%, 26.7%, 22.0%, and 10.7% were on 1, 2, 3, 4, and ≥5 medicines, respectively, for control of their blood pressure with the frequency of adverse effects increasing proportionately up to four medicines. Adverse reactions to antihypertensive medicines were reported by a total of 93 (18.1%) patients. Diuretics - 27.9%, calcium channel blockers (CCBs) - 26.8%, and angiotensin-converting enzyme inhibitors (ACEIs) - 26.8% accounted for most of the adverse reactions seen, notably frequent micturition and headaches (CCB); excessive micturition and dizziness (diuretics); dry irritating cough (ACEI). Notable complaints for all patients using the checklist were increased frequency of micturition, reduction in libido, and headaches. The reactions resulted in the discontinuation and substitution of therapy in 49.5% of the patients.
The characterization of these reactions in Nigerians requires further studies as frequent micturition reported is still a neglected complaint in antihypertensive therapy.
尽管抗高血压药物的使用有所增加,但在尼日利亚,关于其不良反应情况的全面数据却很匮乏。
本研究旨在描述在纯黑人非洲人群中所经历的不良反应特征。
该研究在尼日利亚贝宁城贝宁大学教学医院对年龄≥18岁且同意参与的合格高血压患者中进行。通过患者自我报告和药物诱发症状清单来查找不良反应。
共研究了514例年龄在22 - 97岁的患者(340例女性)。分别有13%、27.6%、26.7%、22.0%和10.7%的患者使用1种、2种、3种、4种及≥5种药物来控制血压,不良反应的发生率随着药物数量增加至4种而相应增加。共有93例(18.1%)患者报告了抗高血压药物的不良反应。利尿剂——27.9%,钙通道阻滞剂(CCB)——26.8%,以及血管紧张素转换酶抑制剂(ACEI)——26.8%占所见不良反应的大部分,特别是尿频和头痛(CCB);排尿过多和头晕(利尿剂);干咳(ACEI)。使用清单的所有患者的显著主诉是尿频增加、性欲减退和头痛。这些反应导致49.5%的患者停药和更换治疗方案。
由于报告的尿频在抗高血压治疗中仍是一个被忽视的主诉,因此需要对尼日利亚人的这些反应特征进行进一步研究。